Stocklytics Platform
Asset logo for symbol IDYA
Ideaya Biosciences
IDYA52
$18.74arrow_drop_down0.72%-$0.13
Asset logo for symbol IDYA
IDYA52

$18.74

arrow_drop_down0.72%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Ideaya Biosciences (IDYA) Stocklytics Forecast

Ideaya Biosciences Inc (IDYA) is a biotechnology company focused on the discovery and development of targeted therapeutics for oncology. The company's innovative approach combines precision medicine and synthetic lethality to develop personalized medicines for patients with genetically defined cancers. With a strong pipeline of potential therapies, Ideaya Biosciences is well-positioned in the rapidly evolving field of oncology.
As for the stock price prediction, the future performance of IDYA is subject to various factors and uncertainties. While AI and machine learning algorithms can provide insights and forecasts, it's important to note that they are not guaranteed predictions. However, analysts and experts have provided some price targets for IDYA. According to these forecasts, the stock price of Ideaya Biosciences Inc is expected to show positive growth in the coming years, with a potential target price of $50 by 2023.
add Ideaya Biosciences  to watchlist

Keep an eye on Ideaya Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Ideaya Biosciences (IDYA) stock?

Analysts have set a target price of $36.7 for Ideaya Biosciences (IDYA), based on forecasts from 30 analysts. The predicted price range extends from a high of $57 to a low of $24. This represents a potential increase of up to 204.08% and a decrease of 28.03% from the current price of $18.75. These forecasts are as of 2022 Sep 13.
help

What are the analyst ratings for Ideaya Biosciences (IDYA) stock?

The analyst ratings for Ideaya Biosciences (IDYA) are distributed as follows: 16 analysts recommend buying, 2 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 18 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Ideaya Biosciences .
help

What is the AI price prediction for Ideaya Biosciences (IDYA) stock?

At present, there is no AI or machine-learning-based price prediction available for Ideaya Biosciences (IDYA) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level